文献速递中医妇科中药与中成药合理使用

基于转录组学与系统网络药理学探索鹅灵胶囊治疗子宫内膜异位症的调控机制

Exploration of the Modulatory Property Mechanism of ELeng Capsule in the Treatment of Endometriosis Using Transcriptomics Combined With Systems Network Pharmacology.
PubMed 文献 · Front Pharmacol · 2021-06-18

本研究采用网络药理学与mRNA转录组分析,探索中药复方鹅灵胶囊治疗子宫内膜异位症的多靶点机制。结果识别出40种化合物和75个与子宫内膜异位症相关蛋白重叠的靶点,机制涉及诱导凋亡、抑制血管生成和调节免疫等功能模块。

要点

  • 鹅灵胶囊可能通过诱导凋亡、抑制血管生成和调节免疫发挥抗子宫内膜异位症作用。
  • 网络药理学提示其机制涉及神经活性配体-受体互动、Toll样受体、VEGF和MAPK信号通路。
  • 转录组分析补充了肌动蛋白与细胞骨架调控、上皮-间质转化和黏着斑等机制模块。

核心结论

  • 鹅灵胶囊对子宫内膜异位症发挥有益作用,其潜在机制可能通过诱导凋亡、调节血管生成、细胞骨架和上皮-间质转化等功能模块实现。

研究设计与样本

  • 采用网络药理学与mRNA转录组分析相结合的研究方法,识别鹅灵胶囊的化合物及与子宫内膜异位症相关蛋白重叠的靶点。

主要发现

  • 识别出40种化合物和75个与子宫内膜异位症相关蛋白重叠的靶点。
  • 网络药理学显示机制基于诱导凋亡、抑制血管生成和调节免疫的功能模块,主要涉及神经活性配体-受体互动、Toll样受体信号通路、VEGF信号和MAPK信号通路。
  • RNA测序分析发现机制主要与肌动蛋白和细胞骨架功能模块调控、上皮-间质转化、黏着斑和免疫相关通路有关。

临床怎么用

  • 本研究为鹅灵胶囊治疗子宫内膜异位症提供了多靶点机制解释,但尚未提供临床用药剂量或疗效阈值,临床使用需结合具体病情和后续研究。

局限性

  • 本研究基于网络药理学和转录组分析,未报告临床样本验证、药效学实验或安全性数据,机制推测需进一步实验证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Endometriosis is a common gynecological disease and causes severe chronic pelvic pain and infertility. Growing evidence showed that traditional Chinese medicine (TCM) plays an active role in the treatment of endometriosis. ELeng Capsule (ELC) is a Chinese medicine formula used for the treatment of endometriosis for several years. However, the mechanisms of ELC have not been fully characterized. In this study, network pharmacology and mRNA transcriptome analysis were used to study various therapeutic targets in ELC. As a result, 40 compounds are identified, and 75 targets overlapped with endometriosis-related proteins. The mechanism of ELC for the treatment of endometriosis is based on the function modules of inducing apoptosis, inhibiting angiogenesis, and regulating immunity mainly through signaling molecules and interaction (neuroactive ligand-receptor interaction), immune system-associated pathways (toll-like receptor signaling pathway), vascular endothelial growth factor (VEGF) signaling, and MAPK signaling pathway based on network pharmacology. In addition, based on RNA-sequence analysis, we found that the mechanism of ELC was predominantly associated with the regulation of the function modules of actin and cytoskeleton, epithelial-mesenchymal transition (EMT), focal adhesion, and immunity-associated pathways. In conclusion, ELC exerted beneficial effects on endometriosis, and the potential mechanism could be realized through functional modules, such as inducing apoptosis and regulating angiogenesis, cytoskeleton, and EMT. This work not only provides insights into the therapeutic mechanism of TCM for treating endometriosis but also offers an efficient way for drug discovery and development from herbal medicine.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Zheng W, Wang J, Wu J, et al. Exploration of the Modulatory Property Mechanism of ELeng Capsule in the Treatment of Endometriosis Using Transcriptomics Combined With Systems Network Pharmacology. Front Pharmacol. 2021. PMID: 34220510. doi:10.3389/fphar.2021.674874

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。